1887

Abstract

Neutralizing monoclonal antibodies (N-MAbs) to serotype G2 and G4 rotaviruses were used to study intraserotypic variation by selection and characterization of N-MAb-resistant antigenic variants and reaction of N-MAbs with prototype rotavirus strains. Two G2-specific N-MAbs reacted with G2 rotaviruses S2, DS-1, RV-5 and RV-6 but not with 1076. Sequence analysis of the gene encoding VP7 of 1076 virus showed that the differences in amino acid sequence between 1076 virus and the other G2 strains at position 147, 213 and 217 correlated with the loss of N-MAb reactivity. Rotavirus variant mutation mapping data suggested that the amino acid difference at position 213 was likely to be of greatest importance. Rotavirus 1076 was defined as monotype b within G2 strains, whereas S2, DS-1, RV-5 and RV-6 belong to monotype a. The molecular basis for G4 subtypes/monotypes was also studied. The monotype G4b N-MAb 3A3 selected an antigenic variant with an amino acid mutation at position 96, whereas variants of the G4a-reactive N-MAb ST-3:1 showed a mutation at position 94, which produced a new, utilized glycosylation site. Neutralization by N-MAb ST-3:1 was also affected by amino acid changes at position 96. Reactions with these N-MAbs show that serotype G2 viruses can be divided into monotypes and confirm the observation that serotype G4 rotaviruses can be subdivided into subtypes/monotypes a and b. The G2 monotypes relate to differences at particular amino acids within antigenic region C and possibly region B, whereas antigenic region A is most important for G4 monotype differentiation.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-77-2-239
1996-02-01
2024-03-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/77/2/JV0770020239.html?itemId=/content/journal/jgv/10.1099/0022-1317-77-2-239&mimeType=html&fmt=ahah

References

  1. Albert M. J., Bishop R. F. 1984; Cultivation of human rotaviruses in cell culture. Journal of Medical Virology 13:377–384
    [Google Scholar]
  2. Bishop R. F., Unicomb L. E., Barnes G. L. 1991; Epidemiology of rotavirus serotypes in Melbourne, Australia, from 1973–1989. Journal of Clinical Microbiology 29:862–868
    [Google Scholar]
  3. Coulson B. S. 1987; Variation in neutralization epitopes of human rotaviruses in relation to genomic RNA polymorphism. Virology 159:209–216
    [Google Scholar]
  4. Coulson B. S. 1993; Typing of human rotavirus VP4 by an enzyme immunoassay using monoclonal antibodies. Journal of Clinical Microbiology 31:1–8
    [Google Scholar]
  5. Coulson B. S., Kirkwood C. 1991; Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype. Journal of Virology 65:5968–5974
    [Google Scholar]
  6. Coulson B. S., Fowler K. J., Bishop R. F., Cotton R. G. H. 1985; Neutralizing monoclonal antibodies to human rotavirus and indication of antigenic drift among strains from neonates. Journal of Virology 54:14–20
    [Google Scholar]
  7. Coulson B. S., Tursi J. M., Mcadam W. J., Bishop R. F. 1986; Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3. Virology 154:301–312
    [Google Scholar]
  8. Coulson B. S., Unicomb L. E., Pitson G. A., Bishop R. F. 1987; Simple and specific enzyme immunoassay using monoclonal antibodies for serotyping rotavirus. Journal of Clinical Microbiology 25:509–515
    [Google Scholar]
  9. Dunn S. J., Ward R. L., McNeal M. M., Cross T. L., Greenberg H. B. 1993; Identification of a new neutralization epitope on VP7 of human serotype 2 rotavirus and evidence for electropherotype differences caused by single nucleotide substitutions. Virology 197:397–404
    [Google Scholar]
  10. Dyall-Smith M. L., Holmes I. H. 1984; Sequence homology between human and animal rotavirus serotype-specific glycoproteins. Nucleic Acids Research 12:3973–3982
    [Google Scholar]
  11. Dyall-Smith M. L., Lazdins L., Tregear G. W., Holmes I. H. 1986; Location of the major antigenic sites involved in rotavirus serotype-specific neutralization. Proceedings of the National Academy of Sciences, USA 83:3465–3468
    [Google Scholar]
  12. Gerna G., Passarani N., Sarasini A., Bataglia M. 1985; Characterization of serotypes of human rotavirus strains by solidphase immune electron microscopy. Journal of Infectious Diseases 152:1143–1151
    [Google Scholar]
  13. Gerna G., Sarasini A., Coulson B. S., Parea M., Torsellini M., Arbustini E., Battaglia M. 1988a; Comparative sensitivities of solid-phase immune electron microscopy and enzyme-linked immunosorbent assay for serotyping of human rotavirus strains with neutralizing monoclonal antibodies. Journal of Clinical Microbiology 26:1383–1387
    [Google Scholar]
  14. Gerna G., Sarasini A., Matteo A., Parea A., Orsolini P., Battaglia M. 1988b; Identification of two subtypes of serotype 4 human rotavirus by using VP7-specific neutralizing monoclonal antibodies. Journal of Clinical Microbiology 26:1388–1392
    [Google Scholar]
  15. Gerna G., Passarani N., Unicomb L. E., Parea M., Sarasini A., Battaglia M., Bishop R. F. 1989; Solid-phase immune electron microscopy and enzyme-linked immunosorbent assay for typing of human rotavirus strains using monoclonal antibodies: a comparative study. Journal of Infectious Diseases 159:335–339
    [Google Scholar]
  16. Glass R. I., Keith J., Nakagomi O., Nakagomi T., Askaa J., Kapikian A. Z., Chanock R. M., Flores J. 1985; Nucleotide sequence of the structural glycoprotein VP7 gene of Nebraska calf diarrhea virus rotavirus: comparison with homologous genes from four strains of human and animal rotaviruses. Virology 141:292–298
    [Google Scholar]
  17. Gorziglia M., Larralde G., Ward R. L. 1990; Neutralization epitopes on rotavirus SA11 4fM outer capsid proteins. Journal of Virology 64:4534–4539
    [Google Scholar]
  18. Green K. Y., Midthun K., Gorziglia M., Hoshino Y., Kapikian A. Z., Chanock R. M., Flores J. 1987; Comparison of the amino acid sequences of the major neutralization protein of four human rotavirus serotypes. Virology 161:153–159
    [Google Scholar]
  19. Green K. Y., Sarasini A., Qian Y., Gerna G. 1992; Genetic variation in rotavirus serotype 4 subtypes. Virology 188:362–368
    [Google Scholar]
  20. Kirkwood C., Masendycz P., Coulson B. S. 1993; Characteristics and location of cross-reactive and serotype-specific neutralization sites on VP7 of human G type 9 rotavirus. Virology 196:79–88
    [Google Scholar]
  21. Lazdins I., Coulson B. S., Kirkwood C., Dyall-Smith M., Masendycz P., Sonza S., Holmes I. H. 1995; Rotavirus antigenicity is affected by the genetic context and glycosylation of VP7. Virology 209:80–89
    [Google Scholar]
  22. Nagesha H. S., Brown L. E., Holmes I. H. 1989; Neutralizing monoclonal antibodies against three serotypes of porcine rotaviruses. Journal of Virology 63:3545–3549
    [Google Scholar]
  23. Palombo E. A., Bishop R. F., Cotton R. G. H. 1993; Sequence conservation within neutralization epitope regions of VP7 and VP4 proteins of human serotype G4 rotavirus isolates. Archives of Virology 133:323–334
    [Google Scholar]
  24. Prasad B. V. V., Wang G. J., Clerz J. P. M., Chiu W. 1988; Three-dimensional structure of rotavirus. Journal of Molecular Biology 199:269–275
    [Google Scholar]
  25. Raj P., Matson D. O., Coulson B. S., Bishop R. F., Taniguchi K., Urasawa S., Greenberg H. B., Estes M. K. 1992; Comparisons of rotavirus VP7-typing monoclonal antibodies by competition binding assay. Journal of Clinical Microbiology 30:704–711
    [Google Scholar]
  26. Ward R. L., McNeal M. M., Clemens J. D., Sack D. A., Rao M., Huda N., Green K. Y., Kapikian A. Z., Coulson B. S., Bishop R. F., Greenberg H. B., Gerna G., Shift G. 1991; Reactivities of serotyping monoclonal antibodies with culture-adapted human rotaviruses. Journal of Clinical Microbiology 29:449–456
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-77-2-239
Loading
/content/journal/jgv/10.1099/0022-1317-77-2-239
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error